Diagnostic Proteomics in Disease Detection & Personalized Medicine

Diagnostic proteomics, driven by innovation and computational tools, is reshaping disease diagnosis and treatment. North America leads the global proteomics market due to increased chronic diseases and advanced diagnostic labs. Technologies within the space, such as “Proteogenomics” is crucial for understanding diseases, especially in cancer diagnostics, while mass spectrometry-based proteomics aids biomarker discovery. Further, “Liquid biopsies”, incorporating proteomics, allow non-invasive disease monitoring and early cancer detection. Use of Artificial intelligence helps in tackling drug design challenges. Despite hurdles like data complexity and regulatory issues, several companies are collaborating to advance proteomic diagnostics for early disease detection.